MEDXF — Stock activity · TradeandTell
MEDX MEDXF $3.10 +$0.19 (+6.63%) prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$1.80 – $3.22
92% from low
Financials Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
Income Balance sheet Cash flow
2019 2020 2021 2022 2023 2024 2025 2026 $33.9M $78.1M $79.7M $76.7M $108.1M $113.1M $108.3M $99.3M $10.4M $23.0M $37.7M $38.8M $48.1M $53.5M $51.7M $44.9M $22.5M $29.4M $42.0M $37.9M $60.0M $59.5M $56.6M $54.4M 66.5% 37.7% 52.7% 49.4% 55.5% 52.6% 52.2% 54.8% $0 $1.5M $4.8M $5.9M $2.9M $8.0M $8.3M $8.9M −$707.3K −$8.1M −$1.4M −$12.4M $8.5M $10.8M $8.2M $5.8M $1.7M $3.4M $7.1M $14.5M $14.3M $19.3M $16.8M $12.7M −$4.9M −$6.2M −$28.3M −$2.9M $1.2M −$214.0K $2.2M −$2.4M -14.4% -7.9% -35.5% -3.8% 1.1% -0.2% 2.1% -2.4% -0.48 -0.46 -1.86 -0.15 0.06 -0.01 0.08 -0.07
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus) Year Est. revenue Est. EPS EPS range # Analysts 2027 $113M $0.28 $0.17–$0.51 3 2028 $138M $0.68 $0.50–$1.03 3 2029 $163M $1.10 $0.97–$1.17 1 2030 $177M $1.28 $1.13–$1.36 1
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate Peer comparison Symbol Price Today Mkt cap P/E MEDXF Medexus Pharmaceuticals Inc. $3.10 +6.63% $100M — DBCCF Decibel Cannabis Company Inc. $0.08 +0.24% $48M — ETST Earth Science Tech, Inc. $0.16 +0.00% $46M — FLOOF Flower One Holdings Inc. $0.00 +0.00% $4731 — INIS Radnostix, Inc. $0.07 +0.00%
Held by traders on TradeandTell No one on the platform currently holds MEDXF.
Super investors & insiders Institutions holding (13F)
No tracked institution reports a position in MEDXF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell No one on the platform has traded MEDXF yet.
Report a bug MILFF 1CM Inc. $0.08 +0.00% $9M —
NICXF Nicox S.A. $0.30 +0.00% $31M —
Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$MEDXF chatter on StockTwits https://nfne.ws/302939 $MEDXF $MDP.TSX @MedexusInc #OrphanDrug #RareDisease #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #Hea
View on StockTwits ↗ https://nfne.ws/301705 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ $MEDXF $PSNL $NVO https://finance.yahoo.com/sectors/healthcare/articles/medexus-announces-license-supply-deal-213000897.html
View on StockTwits ↗ https://nfne.ws/300810 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ $MEDXF Their April 15th PR is full of grammar and spelling mistakes. Not a great sign.
View on StockTwits ↗ https://nfne.ws/292763 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ $ACB $MEDXF Don’t try to catch a falling knife unless you’ve got hooves and a budget for a takeover. (Image: $MSFT AI)
View on StockTwits ↗ https://nfne.ws/283622 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ https://nfne.ws/282535 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ $ACB $MEDXF Talking scales: Only consider buying shares here if you could also buy the company in full. (Mulholland Drive, Movie 2001)
View on StockTwits ↗ There is some resilience here. It just takes a buyout. $ACB $ATXS $MEDXF (Mutiny on the Bounty, Movie 1935)
View on StockTwits ↗ https://nfne.ws/275259 $MEDXF $MDP.TSX @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmac
View on StockTwits ↗ Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Valuation Trading at 0.7× sales vs its 0.4× historical median P/S.
Fair value ≈ $1.90 · price $3.10 today
Overvalued · 63% above Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
